Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Trolle Andersen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Acta Orthopaedica|May 8, 2019
Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) groupAlma B Pedersen, Ina Trolle Andersen, Soren Overgaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2021
Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort StudyMette Nørgaard, Ina Trolle Andersen, Uffe Heide-Jørgensen, et al.
Clinical Epidemiology|July 3, 2020
Rheumatoid Arthritis as a Risk Factor for Coronary Artery Calcification and Obstructive Coronary Artery Disease in Patients with Chest Pain: A Registry Based Cross-Sectional StudyAndreas Bugge Tinggaard, Annette de Thurah, Ina Trolle Andersen, et al.
RMD Open|January 21, 2020
<i>​</i>Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatmentAnnette de Thurah, Ina Trolle Andersen, Andreas Bugge Tinggaard, et al.
Acta Orthopaedica|April 13, 2022
Association of perioperative thromboprophylaxis on revision rate due to infection and aseptic loosening in primary total hip arthroplasty - new evidence from the Nordic Arthroplasty Registry Association (NARA)Thea Emily Benson, Ina Trolle Andersen, Søren Overgaard, et al.
Acta Orthopaedica|December 28, 2022
Association between duration of anticoagulant thromboprophylaxis and revision rate in primary total hip arthroplasty: a Danish and Norwegian nationwide cohort studyDennis Vinther, Aurelie Mailhac, Ina Trolle Andersen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 18, 2021
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015Tina Bech Olesen, Ina Trolle Andersen, Anne Gulbech Ording, et al.
European Heart Journal. Digital Health|January 30, 2023
Advanced heart sound analysis as a new prognostic marker in stable coronary artery diseaseSimon Winther, Louise Nissen, Samuel Emil Schmidt, et al.
Journal of Cardiovascular Computed Tomography|September 3, 2021
Prognostic value of myocardial perfusion imaging after first-line coronary computed tomography angiography: A multi-center cohort studySimon Winther, Ina Trolle Andersen, Lars Christian Gormsen, et al.
JACC. Cardiovascular Imaging|July 18, 2021
Reduction of Myocardial Infarction and All-Cause Mortality Associated to Statins in Patients Without Obstructive CADKristian A Øvrehus, Axel Diederichsen, Erik L Grove, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Acta Orthopaedica|May 8, 2019
Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) groupAlma B Pedersen, Ina Trolle Andersen, Soren Overgaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2021
Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort StudyMette Nørgaard, Ina Trolle Andersen, Uffe Heide-Jørgensen, et al.
Clinical Epidemiology|July 3, 2020
Rheumatoid Arthritis as a Risk Factor for Coronary Artery Calcification and Obstructive Coronary Artery Disease in Patients with Chest Pain: A Registry Based Cross-Sectional StudyAndreas Bugge Tinggaard, Annette de Thurah, Ina Trolle Andersen, et al.
RMD Open|January 21, 2020
<i>​</i>Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatmentAnnette de Thurah, Ina Trolle Andersen, Andreas Bugge Tinggaard, et al.
Acta Orthopaedica|April 13, 2022
Association of perioperative thromboprophylaxis on revision rate due to infection and aseptic loosening in primary total hip arthroplasty - new evidence from the Nordic Arthroplasty Registry Association (NARA)Thea Emily Benson, Ina Trolle Andersen, Søren Overgaard, et al.
Acta Orthopaedica|December 28, 2022
Association between duration of anticoagulant thromboprophylaxis and revision rate in primary total hip arthroplasty: a Danish and Norwegian nationwide cohort studyDennis Vinther, Aurelie Mailhac, Ina Trolle Andersen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 18, 2021
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015Tina Bech Olesen, Ina Trolle Andersen, Anne Gulbech Ording, et al.
European Heart Journal. Digital Health|January 30, 2023
Advanced heart sound analysis as a new prognostic marker in stable coronary artery diseaseSimon Winther, Louise Nissen, Samuel Emil Schmidt, et al.
Journal of Cardiovascular Computed Tomography|September 3, 2021
Prognostic value of myocardial perfusion imaging after first-line coronary computed tomography angiography: A multi-center cohort studySimon Winther, Ina Trolle Andersen, Lars Christian Gormsen, et al.
JACC. Cardiovascular Imaging|July 18, 2021
Reduction of Myocardial Infarction and All-Cause Mortality Associated to Statins in Patients Without Obstructive CADKristian A Øvrehus, Axel Diederichsen, Erik L Grove, et al.
Pageof 3